Infinium Global Research Psoriasis Therapeutics Market | 页面 2

A latest report has been added to the wide database of Psoriasis Therapeutics Market by Infinium Global Research. This report studies the
Psoriasis Therapeutics Market by molecule (biologics, small molecules), route of administration (oral, parenteral, topical), dosage forms
(solid, liquid, EMI-solid), mechanism of action (TNF inhibitors, PDE4 inhibitors, il blocker) market status and outlook of global and major
regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in
recent years and to forecast the values for the next six years. Psoriasis Therapeutics Market provides opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major
companies in the Psoriasis Therapeutics Market. According to report the global psoriasis therapeutics market is expected to grow at a CAGR
of 9.7% over the forecast period of 2017 - 2023.
Segments Covered
The report on global psoriasis therapeutics market covers segments such as molecule, route of administration, dosage forms and
mechanism of action. The molecule segments include biologics and small molecules. On the basis of route of administration the global
psoriasis therapeutics market is categorized into oral, parenteral and topical. On the basis of dosage forms the global psoriasis therapeutics
market is categorized into solid, liquid and emi-solid. On the basis of mechanism of action the global psoriasis therapeutics market is
categorized into TNF inhibitors, PDE4 inhibitors, il blocker and others.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific and Rest of the World. In this section
the key trends and market size for each geography is provided over the period of 2015 – 2023. The countries covered in the Americas region
include the U.S., Canada and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia among others. Moreover, the
countries covered in the European region include Germany, U.K., France, Spain and Rest of Europe. The U.S. drives the growth in the
Americas region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to
rapid growth in economies such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period
of 2017 - 2023.
Companies Profiled:
The report provides profiles of the companies in the global Psoriasis therapeutics market such as, Amgen, Inc., Johnson & Johnson, Eli Lilly
and Company, AstraZeneca, Novartis AG, AbbVie Inc. and Celgene Corporation.